Pathogenesis of irritable bowel syndrome: The mast cell connection

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 2, 2005, Pages 129-140

  Santos, Javier ^a,b   Guilarte, Mar ^a   Alonso, Carmen ^a   Malagelada, J R ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CROMOGLYCATE DISODIUM; FC RECEPTOR; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN RECEPTOR; KETOTIFEN; LEUKOTRIENE; NEUROPEPTIDE; PROTEIN TYROSINE KINASE INHIBITOR; PROTEINASE ACTIVATED RECEPTOR ANTAGONIST; RECEPTOR BLOCKING AGENT; SEROTONIN; SUBSTANCE P; TRANILAST; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANGIOGENESIS; CELL ACTIVATION; CELL ACTIVITY; CELL COMMUNICATION; CELL FUNCTION; COLD STRESS; CONSTIPATION; CYTOKINE PRODUCTION; DIARRHEA; EFFECTOR CELL; ELECTROLYTE TRANSPORT; FOOD ALLERGY; FOOD INTAKE; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE INNERVATION; INTESTINE MOTILITY; INTESTINE MUCOSA; IRRITABLE COLON; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; NONHUMAN; PAIN; PARACRINE SIGNALING; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; TISSUE DISTRIBUTION; TISSUE REPAIR;

ANIMALS; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL MUCOSA; INTESTINES; IRRITABLE BOWEL SYNDROME; MAST CELLS;

EID: 13244284658     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520410009410     Document Type: Review

References (168)

1. Horwitz BJ, Fisher RS. The irritable bowel syndrome. N Engl J Med 2001;344:1846-50.
2. Creed F, Ratcliffe J, Fernández L, Tomenson B, Palmer S, Rigby C, et al. Health-related quality of life and health care cost in severe, refractory irritable bowel syndrome. Ann Intern Med 2001;134:S860-2.
3. Drossman DA. Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome? Am J Med 1999;107:41S-50S.
4. Janssen HAM, Janssen HA, Muris JW, Knotterus JA. The clinical course and prognostic determinants of the irritable bowel syndrome: a literature review. Scand J Gastroenterol 1998;33:561-5.
5. Bennett EJ, Bennett EJ, Tennant CC, Piesse C, Badcock CA, Kellow JE. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 1998;43:256-61.
6. Zar S, Kumar D, Benson MJ. Food hypersensitivity and irritable bowel syndrome. [review article]. Aliment Pharmacol Ther 2001;15:439-49.
7. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003;124:1662-71.
8. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002;2:773-86.
9. Kirshenbaum AS, Kessler SW, Goff JP, Metcalfe DD. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol 1991;146:1410-5.
10. Metcalfe DD, Baram D, Mekori Y A. Mast cells. Physiol Rev 1997;77:1033-79.
11. Henz BM, Maurer M, Lippen U, Worm M, Babina M. Mast cell as initiators of immunity and host defense. Exp Dermatol 2001;10:1-10.
12. Gurish MF, Austen F. The diverse role of mast cells. J Exp Med 2001;194:F1-5.
13. Galli SJ, Wershil BK. The two faces of the mast cell. Nature 1996;381:21-2.
14. Maurer M, Theoharides T, Granstein RD, Bischoff SC, Bienenstock J, Henz B, et al. What is the physiological function of mast cells? Exp Dermatol 2003;12:886-910.
15. Redegeld FA, Nijkamp FP. Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions? Trends Immunol 2003;24:181-5.
16. Genovese A, Borgia G, Bouvet JP, Detoraki A, de Paulis A, Piazza M, et al. Protein Fv produced during viral hepatitis is an endogenous immunoglobulin superantigen activating human heart mast cells. Int Arch Allergy Immunol 2003;132:336-45.
17. Oka T, Sato K, Hori M, Ozaki H, Karaki H. FcεRI cross-linking- induced actin assembly mediates calcium signalling in RBL-2H3 mast cells. Br J Pharmacol 2002;136:837-46.
18. Crivellato E, Beltrami CA, Mallardi F, Ribatti D. The mast cell: an active participant or an innocent bystander. Histol Histopathol 2004;19:259-70.
19. Stenton GR, Befus D. Intestinal mast cells. In: Brostoff J, Challacombe SJ, editors. Food allergy and intolerance. London: Elsevier; 2002. p. 85-102.
20. Eggleston PA, Kagey-Sobotka A, Schleimer RP, Lichtenstein LM. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am Rev Respir Dis 1984;130:86-91.
21. Candussio L, Crivellato E, Decorti G, Bartoli-Klugmann F, Mallardi F. Effect of low temperature on mast cell exocytosis. Early cytoplasmic vesicle formation and the role of cytoskeleton. J Submicrosc Cytol Pathol 1999;31:477-85.
22. Proud D, Bailey GS, Naclerio RM, Reynolds CJ, Cruz AA, Eggleston PA, et al. Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions. J Allergy Clin Immunol 1992;89:1098-110.
23. Kronauer C, Eberlein-Konig B, Ring J, Behrendt H. Influence of UVB, UVA and UVA1 irradiation on histamine release from human basophils and mast cells in vitro in the presence and absence of antioxidants. Photochem Photobiol 2003;77:531-4.
24. Kanwar S, Kubes P. Mast cells contribute to ischemia-reperfusion-induced granulocyte infiltration and intestinal dysfunction. Am J Physiol 1994;267 (2 Pt 1):G316-21.
25. Sharma BB, Apgar J, Liu FT. Mast cells: receptors, secretagogues, and signaling. Clin Rev Allergy Immunol 2002;22:119-48.
26. Gruber BI, Marchese MJ, Kew R. Angiogenic factors stimulate mast cell migration. Blood 1995;86:2488-93.
27. Osipchuk Y, Cahalan M. Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells. Nature 1992;359:241-4.
28. Freeman JG, Ryan JJ, Shelburne CP, Bailey DP, Bouton LA, Narasimhachari N, et al. Catecholamines in murine bone marrow derived mast cells. J Neuroimmunol 2001;119:231-8.
29. Galli SJ. New concepts about the mast cell. N Engl J Med 1993;328:257-65.
30. Saito H, Nakajima T, Matsumoto K. Human mast cell transcriptome project. Int Arch Allergy Immunol 2001;125:1-8.
31. Barrett KE. Mechanisms for amplified mediator release from colonic mast cells: implications for intestinal inflammatory diseases. World J Gastroenterol 2004;10:617-9.
32. Murphy GF, Austen FK, Fonferko E, Sheffer AL. Morphologically distinctive forms of cutaneous mast cell degranulation induced by cold and mechanical stimuli: an ultrastructural study. J Allergy Clin Immunol 1987;80:603-11.
33. Kaminer MS, Murphy GF, Zweiman B, Lavker RM. Connective tissue mast cells exhibit time-dependent degranulation heterogeneity. Clin Diagn Lab Immunol 1995;2:297-301.
34. Dvorak AM, McLeod RS, Onderdonk A, Monahan-Earley RA, Cullen JB, Antonioli DA, et al. Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo. Int Arch Allergy Immunol 1992;99:74-83.
35. Theoharides TC, Bondy PK, Tsakalos ND, Askenase PW. Differential release of serotonin and histamine from mast cells. Nature 1982;20;297:229-31.
36. Theoharides TC, Cochrane DE. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 2004;146:1-12.
37. Crivellato E, Nico B, Mallardi F, Beltrami CA, Ribatti D. Piecemeal degranulation as a general secretory mechanism? Anat Rec 2003;274A:778-84.
38. Greenberg G, Burnstock G. A novel cell-to-cell interaction between mast cells and other cell types. Exp Cell Res 1983;147:1-13.
39. Lorentz A, Schwenberg S, Sellge G, Manns MP, Bischoff SC. Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. J Immunol 2000;164:43-8.
40. Galli SJ. New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990;62:5-33.
41. Li L, Meng XW, Krilis SA. Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand. J Immunol 1996;156:4839-44.
42. Knight PA, Wright SH, Brown JK, Huang X, Sheppard D, Miller HR. Enteric expression of the integrin alpha(v)beta(6) is essential for nematode-induced mucosal mast cell hyperplasia and expression of the granule chymase, mouse mast cell protease-1. Am J Pathol 2002;161:771-9.
43. Gurish MF, Pear WS, Stevens RL, Scott ML, Sokol K, Ghildyal N, et al. Tissue-regulated differentiation and maturation of a v-abl-immortalized mast cell-committed progenitor. Immunity 1995;3:175-86.
44. Friend DS, Ghildyal N, Austen KF, Gurish MF, Matsumoto R, Stevens RL. Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype. J Cell Biol 1996;135:279-90.
45. Frossi B, De Carli M, Pucillo C. The mast cell: an antenna of the microenvironment that dictates the immune response. J Leukoc Biol 2004;75:579-85.
46. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST. Heterogeneity of human mast cells based on cytokine content. J Immunol 1995;155:297-307.
47. Lin TJ. Mast cells and eosinophils in mucosal defenses and pathogenesis. In: Ogra PL, Mestecky J, Lamm ME, Strober, Bienenstock J, McGhee JR, editors. Mucosal immunology. San Diego, CA: CRC Press; 1999. p. 469-82.
48. Bischoff SC, Wedemeyer J, Herrmann A, Meier PN, Trautwein C, Cetin Y, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996;28:1-13.
49. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986;83:4464-8.
50. Nilsson G, Alving K, Alstedt S, Hokfelt T, Lundberg JM. Peptidergic innervation of rat lymphoid tissue and lung: relation to mast cells and sensitivity to capsaicin and immunization. Cell Tissue Res 1990;262:125-33.
51. Williams RM, Berthoud HR, Stead RH. Vagal afferent nerve fibres contact mast cells in rat small intestinal mucosa. Neuroimmunomodulation 1997;4:266-70.
52. Newson B, Dahlstrom A, Enerback L, Ahlman H. Suggestive evidence for a direct innervation of mucosal mast cells. Neuroscience 1983;10:565-70.
53. Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA 1987;84:2975-9.
54. Santos J, Bienenstock J, Perdue M. Innervation of lymphoid tissue and functional consequences of neurotransmitter and neuropeptide release. In: Brostoff J, Challacombe SJ, editors. Food allergy and intolerance. London: Elsevier; 2002. p. 51-67.
55. Stead RH, Dixon MF, Bramwell NH, Riddell RH, Bienenstock J. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 1989;97:575-85.
56. Feher E, Fodor M, Burnstock G. Distribution of somatostatin- immunereactive nerve fibres in Peyer's patches. Gut 1992;33:1195-8.
57. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693-702.
58. Dvorak AM, McLeod RS, Onderdonk AB, Monahan-Earley RA, Cullen JB, Antonioli DA, et al. Human gut mucosal mast cells: ultrastructural observations and anatomic variation in mast cell-nerve associations in vivo. Int Arch Allergy Immunol 1992;98:158-68.
59. Hermes B, Welker P, Feldmann-Böddeker I, Krüger-Krasagakis S, Hartmann K, Zuberbier T, et al. Expression of mast cell growth, modulating and chemotactic factors and their receptors in human cutaneous scars. J Invest Dermatol 2001;116:387-93.
60. 14C-histamine release induced by noradrenaline in mouse neoplastic mast cells. Agents Actions 1975;5:417-23.
61. Masini E, Fantozzi R, Blandina P, Brunelleschi S, Mannaioni PF. The riddle of cholinergic histamine release from mast cells. In: Ellis GP, West GB, editors. Progress in medicinal chemistry. Amsterdam: Elsevier 1985;22:267-91.
62. Wessler I, Kilbinger H, Bittinger F, Unger R, Kirkpatrick CJ. The non-neuronal cholinergic system in humans: expression, function and pathophysiology. Life Sci 2003;72:2055-61.
63. Hofstra CL, Desai PJ, Thurmond RL, Fung-Leung WP. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 2003;305:1212-21.
64. Chen H, Centola M, Altschul SF, Metzger H. Characterization of gene expression in resting and activated mast cells. J Exp Med 1998;188:1657-68.
65. Suzuki R, Furuno T, McKay DM, Wolvers D, Teshima R, Nakanishi M, et al. Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J Immunol 1999;163:2410-5.
66. Suzuki R, Furuno T, Teshima R, Nakanishi M. Bidirectional relationship of in vitro mast cell-nerve communication observed by confocal laser scanning microscopy. Biol Pharm Bull 2001;24:291-4.
67. McFadden D, Zinner MJ, Jaffe BM. Substance P-induced intestinal secretion of water and electrolytes. Gut 1986;27:267-72.
68. Riegler M, Castagliuolo I, So PT, Lotz M, Wang C, Wlk M, et al. Effects of substance P on human colonic mucosa in vitro. Am J Physiol 1999;276:G1473-83.
69. Wang L, Stanisz AM, Wershil BK, Galli SJ, Perdue MH. Substance P induces ion secretion in mouse small intestine through effects on enteric nerves and mast cells. Am J Physiol 1995;269:G85-92.
70. Bischoff SC, Schwengberg S, Lorentz A, Manns MP, Bektas H, Sann H, et al. Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells. Neurogastroenterol Motil 2004;16:185-93.
71. Yu LCH, Perdue MH. Role of mast cells in intestinal mucosal function: studies in models of hypersensitivity and stress. Immunol Rev 2001;179:61-73.
72. Santos J, Perdue MH. Immunological regulation of intestinal epithelial transport. Digestion 1998;59:404-8.
73. Perdue MH, Marshall J, Masson S. Ion transport abnormalities in inflamed rat jejunum. Involvement of mast cells and nerves. Gastroenterology 1990;98:561-7.
74. Perdue MH, Ramage JK, Burget D, Marshall J, Masson S. Intestinal mucosal injury is associated with mast cell activation and leukotriene generation during Nippostrongylus-induced inflammation in the rat. Dig Dis Sci 1989;34:724-31.
75. Arizono N, Matsuda S, Hattori T, Kojima Y, Maeda T, Galli SJ. Anatomical variation in mast-cell nerve associations in the rat small intestine, heart, lung and skin. Lab Invest 1990;62:626-34.
76. Miller HRP, Woodbury RG, Huntley JK, Newlands G. Systemic release of mucosal mast cell protease in primed rats challenged with Nippostrongylus brasiliensis. Immunology 1983;49:471-9.
77. D'Inca R, Ramage JK, Hunt RH, Perdue MH. Antigen-induced mucosal damage and restitution in the small intestine of the immunized rat. Int Arch Allergy Appl Immunol 1990;91:270-7.
78. Castro GA, Harari Y, Russell DA. Mediators of anaphylaxis-induced ion transport changes in small intestine. Am J Physiol 1987;253:G540-8.
79. Zhang S, Myers S, Castro GA. Inhibition of anaphylaxis-evoked intestinal fluid secretion by the dual application of an H1-antagonist and cyclooxygenase inhibitor. Gastroenterology 1991;100:922-8.
80. Perdue MH, Gall DG. Intestinal anaphylaxis in the rat: jejunal response to in vitro antigen exposure. Am J Physiol 1986;250:G427-31.
81. Crowe SE, Sestini P, Perdue MH. Allergic reactions of rat jejunal mucosa. Ion transport responses to luminal antigen and inflammatory mediators. Gastroenterology 1990;99:74-82.
82. Perdue MH, Gall DG. Transport abnormalities during intestinal anaphylaxis in the rat: effect of antiallergic compounds. J Allergy Clin Invest 1983;76:498-503.
83. Crowe SE, Perdue MH. Gastrointestinal food hypersensitivity: basic mechanisms of pathophysiology. Gastroenterology 1992;103:1075-95.
84. Cuffe JE, Bertog M, Velazquez-Rocha S, Dery O, Bunnett N, Korbmacher C. Basolateral PAR-2 receptors mediate KCl secretion and inhibition of Na+ absorption in the mouse distal colon. J Physiol 2002;539:209-22.
85. Mall M, Gonska T, Thomas J, Hirtz S, Schreiber R, Kunzelmann K. Activation of ion secretion via proteinase-activated receptor-2 in human colon. Am J Physiol Gastrointest Liver Physiol 2002;282:G200-10.
86. Theodorou V, Fioramonti J, Junien JL, Bueno L. Anaphylactic colonic hypersecretion in cow's milk sensitized guinea-pigs depends upon release of interleukin-1, prostaglandins and mast cell degranulation. Aliment Pharmacol Ther 1994;8:301-7.
87. Vergnolle N, Macnaughton WK, Al-Ani B, Saifeddine M, Wallace JL, Hollenberg MD. Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport. Proc Natl Acad Sci USA 1998;95:7766-71.
88. Zund G, Madara JL, Dzus AL, Awtrey CS, Colgan SP. Interleukin-4 and interleukin-13 differentially regulate epithelial chloride secretion. J Biol Chem 1996;271:7460-4.
89. Holmgren J, Fryklund J, Larsson H. Gamma-interferon-mediated down-regulation of electrolyte secretion by intestinal epithelial cells: a local immune mechanism? Scand J Immunol 1989;30:499-503.
90. Baird AW, Coombs RRA, McLaughlin P, Cuthbert AW. Immediate hypersensitivity reactions to cow milk proteins in isolated epithelium from ileum of milk drinking guinea pigs. Comparison with colonic epithelia. Int Arch Allergy Appl Immunol 1984;75:255-63.
91. Perdue MH, Masson S, Wershil BK, Galli SJ. Role of mast cells in ion transport abnormalities associated with intestinal anaphylaxis. Correction of diminished secretory response in genetically mast cell deficient W/W mice by bone marrow transplantation. J Clin Invest 1991;87:687-93.
92. Baird AW, Cuthbert AW, McVinish LJ. Type I hypersensitivity reactions in reconstructed tissues using syngeneic cell types. Br J Pharmacol 1987;91:857-69.
93. Crowe SE, Perdue MH. Anti-immunoglobulin E-stimulated ion transport in human large and small intestine. Gastroenterology 1993;105:764-72.
94. Crowe SE, Luthra GK, Perdue MH. Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease. Gut 1997;41:785-92.
95. Santos J, Bayarri C, Saperas E, Nogueiras C, Antolin M, Mourelle M, et al. Characterisation of immune mediator release during the immediate response to segmental mucosal challenge in the jejunum of patients with food allergy. Gut 1999;45:553-8.
96. Crowe SE, Soda K, Stanisz AM, Perdue MH. Intestinal permeability in allergic rats: nerve involvement in antigen-induced changes. Am J Physiol 1993;264:G617-23.
97. Ramage JK, Stanisz A, Scicchitano R, Hunt RH, Perdue MH. Effect of immunologic reactions on rat intestinal epithelium. Correlation of increased permeability to chromium 51-labeled ethylenediaminetetraacetic acid and ovalbumin during acute inflammation and anaphylaxis. Gastroenterology 1988;94:1368-75.
98. King SJ, Miller HR. Anaphylactic release of mucosal mast cell protease and its relationship to gut permeability in Nippostrongylus-primed rats. Immunology 1984;51:653-60.
99. Byars EN, Ferraresi RW. Intestinal anaphylaxis in the rat as a model of food allergy. Clin Exp Immunol 1976;24:352-6.
100. Scudamore CL, Thornton EM, McMillan L, Newlands GF, Miller HR. Release of the mucosal mast cell granule chymase, rat mast cell protease-II, during anaphylaxis is associated with the rapid development of paracellular permeability to macromolecules in rat jejunum. J Exp Med 1995;182:1871-81.
101. Miller MJS, Zhang XJ, Barkemeyer B, Sadowska-Krowicka H, Eloby-Childress S, Gu X, et al. Potential role of histamine monochloramine in a rabbit model of ileitis. Scand J Gastroenterol 1991;26:85-8.
102. Scudamore CL, Jepson MA, Hirst BH, Miller HR. The rat mucosal mast cell chymase, RMCP-II, alters epithelial cell monolayer permeability in association with altered distribution of the tight junction proteins ZO-1 and occludin. Eur J Cell Biol 1998;75:321-30.
103. Coelho AM, Vergnolle N, Guiard B, Fioramonti J, Bueno L. Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. Gastroenterology 2002;122:1035-47.
104. Santos J, Saperas E, Mourelle M, Antolin M, Malagelada JR. Regulation of intestinal mast cells and luminal protein release by cerebral thyrotropin-releasing hormone in rats. Gastroenterology 1996;111:1465-73.
105. Berin MC, Kiliaan AJ, Yang PC, Groot JA, Tamianu JAJM, Perdue MH. Rapid transepithelial antigen transport in rat jejunum: impact of sensitization and the hypersensitivity reaction. Gastroenterology 1997;113:856-64.
106. Berin MC, Kiliaan AJ, Yang P-C, Groot JA, Kitamura Y, Perdue MH. The influence of mast cells on pathways of transepithelial antigen transport in rat intestine. J Immunol 1998;161:2561-6.
107. McDermott JR, Bartram RE, Knight PA, Miller HR, Garrod DR, Grencis RK. Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc Natl Acad Sci USA 2003;100:7761-6.
108. Saunders PR, Kosecka U, McKay DM, Perdue MH. Acute stressors stimulate ion secretion and increase epithelial permeability in rat intestine. Am J Physiol 1994;267: G794-9.
109. Santos J, Saunders PR, Hanssen NP, Yang PC, Yates D, Groot JA, et al. Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat. Am J Physiol 1999;277:G391-9.
110. Santos J, Yang PC, Soderholm JD, Benjamin M, Perdue MH. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut 2001;48:630-6.
111. Santos J, Perdue MH. Stress and neuroimmune regulation of gut mucosal function. Gut 2000;47 Suppl 4:49-51.
112. Santos J, Benjamin M, Yang PC, Prior T, Perdue MH. Chronic stress impairs rat growth and jejunal epithelial barrier function: role of mast cells. Am J Physiol Gastrointest Liver Physiol 2000;278:G847-54.
113. Soderholm JD, Yang PC, Ceponis P, Vohra A, Riddell R, Sherman PM, et al. Chronic stress induces mast-cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology 2002;123:1099-108.
114. Santos J, Saperas E, Nogueiras C, Mourelle M, Antolin M, Cadahia A, et al. Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology 1998;114:640-8.
115. Alonso C, Santos J, Guilarte M, Vicario M, Antolin M, Saperas E, et al. Corticotropin-releasing hormone promotes jejunal proinflammatory responses in IBS patients. Gastroenterology 2004;126 Suppl 2:A703.
116. Scott RB, Gall DG, Maric M. Mediation of food protein-induced jejunal longitudinal smooth muscle contraction in sensitized rats. Am J Physiol Gastrointest Liver Physiol 1990;259:G6-14.
117. Oliver MR, Tan DT, Kirk DR, Rioux KP, Scott RB. Colonic and jejunal motor disturbances after colonic antigen challenge of sensitized rat. Gastroenterology 1997;112:1996-2005.
118. Fargeas MJ, Theodourou V, Fioramonti J, Bueno L. Relationship between mast cell degranulation and jejunal myoelectric alterations in rats. Gastroenterology 1992;102:157-62.
119. Scott RB, Tan DTM. Mediation of altered motility in food protein induced intestinal anaphylaxis in Hooded Lister rat. Can J Physiol Pharmacol 1996;74:320-30.
120. Castex N, Fioramonti J, Fargeas MJ, More J, Bueno L. Role of 5-HT3 receptors and afferent fibers in the effects of mast cell degranulation on colonic motility in rats. Gastroenterology 1994;107:976-84.
121. Gay J, Fioramonti J, Garcia-Villar R, Bueno L. Alterations of intestinal motor responses to various stimuli after Nippostrongylus brasiliensis infection in rats: role of mast cells. Neurogastroenterol Motil 2000;12:207-14.
122. Tache Y, Perdue MH. Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol Motil 2004;16 Suppl 1:137-42.
123. Monnikes H, Tebbe JJ, Hildebrandt M, Arck P, Osmanoglou E, Rose M, et al. Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity. Dig Dis 2001;19:201-11.
124. Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1998;42:845-9.
125. Zhao A, Shea-Donohue T. PAR-2 agonists induce contraction of murine small intestine through neurokinin receptors. Am J Physiol Gastrointest Liver Physiol 2003;285: G696-703.
126. Mule F, Baffi MC, Capparelli A, Pizzuti R. Involvement of nitric oxide and tachykinins in the effects induced by protease-activated receptors in rat colon longitudinal muscle. Br J Pharmacol 2003;139:598-604.
127. 2 receptors. Eur J Pharmacol 1997;337:279-82.
128. McLean PG, Picard C, Garcia-Villar R, Ducos de Lahitte R, More J, Fioramonti J, et al. Role of kinin B1 and B2 receptors and mast cells in post intestinal infection-induced hypersensitivity to distension. Neurogastroenterol Motil 1998;10:499-508.
129. Palmer JM. Immunomodulation of electrical and synaptic behaviour of myenteric neurons of guinea-pig small intestine during infection with Trichinella spiralis. In: Snape WJ, Collins SM, editors. Effects of immune cells and inflammation on smooth muscle and enteric nerves. Boca Raton, Fl: CRC Press; 1991. p. 181-95.
130. Sharkey KA, Mawe GM. Neuroimmune and epithelial interactions in intestinal inflammation. Curr Opin Pharmacol 2002;2:669-77.
131. Gue M, Del Rio-Lacheze C, Eutamene H, Theodorou V, Fioramonti J, Bueno L. Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells. Neurogastroenterol Mot 1997;9:271-9.
132. Coelho AM, Fioramonti J, Bueno L. Mast cell degranulation induces delayed rectal allodynia in rats: role of histamine and 5-HT. Dig Dis Sci 1998;43:727-37.
133. Libel R, Biddle WL, Miner PB Jr. Evaluation of anorectal physiology in patients with increased mast cells. Dig Dis Sci 1993;38:877-81.
134. Costa JJ, Weller PF, Galli SJ. The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA 1997;278:1815-22.
135. Konaka A, Nishijima M, Tanaka A, Kunikata T, Kato S, Takeuchi K. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats. J Physiol Pharmacol 1999;50:25-38.
136. Wershil BK, Castagliuolo I, Pothoulakis C. Direct evidence of mast cell involvement in Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology 1998;114:956-64.
137. Araki Y, Andoh A, Fujiyama Y, Bamba T. Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats. Clin Exp Immunol 2000;119:264-9.
138. Andoh A, Kimura T, Fukuda M, Araki Y, Fujiyama Y, Bamba T. Rapid intestinal ischaemia-reperfusion injury is suppressed in genetically mast cell-deficient Ws/Ws rats. Clin Exp Immunol 1999;116:90-3.
139. Zheng H, Wang J, Hauer-Jensen M. Role of mast cells in early and delayed radiation injury in rat intestine. Radiat Res 2000;153:533-9.
140. Wershil BK, Furuta GT, Wang ZS, Galli SJ. Mast cell-dependent neutrophil and mononuclear cell recruitment in immunoglobulin E-induced gastric reactions in mice. Gastroenterology 1996;110:1482-90.
141. Yang PC, Berin MC, Yu L, Perdue MH. Mucosal pathophysiology and inflammatory changes in the late phase of the intestinal allergic reaction in the rat. Am J Pathol 2001;158:681-90.
142. McPherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nature Rev Immunol 2004;4:478-85.
143. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361:512-9.
144. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 1996;381:77-80.
145. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996;381:77-80.
146. Dainese R, De Galliani EA, Lazzari F, Di Leo V, Naccarato R. Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol 1999;94:1892-7.
147. Andre F, Andre C, Colin L, Cavagna S. IgE in stools as indicator of food sensitization. Allergy 1995;50:328-33.
148. Nanda R, James R, Smith H, Dudley CR, Jewel DP. Food intolerance and the irritable bowel syndrome. Gut 1989;30:1099-104.
149. Simonato B, De Lazzari F, Pasini G, Polato F, Giannattasio M, Gemignani C, et al. IgE binding to soluble and insoluble wheat flour proteins in atopic and non-atopic patients suffering from gastrointestinal symptoms after wheat ingestion. Clin Exp Allergy 2001;31:1771-8.
150. Bischoff SC, Mayer J, Meier PN, Zeck-Kapp G, Manns MP. Clinical significance of the colonoscopic allergen provocation test. Int Arch Allergy Immunol 1997;113:348-51.
151. Bengtsson U, Knutson TW, Knutson L, Dannaeus A, Hallgren R, Ahlstedt S. Eosinophil cationic protein and histamine after intestinal challenge in patients with cow's milk intolerance. J Allergy Clin Immunol 1997;100:216-21.
152. Stefanini GF, Saggioro A, Alvisi V, Angelini G, Capurso L, di Lorenzo G, et al. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol 1995;30:535-41.
153. Barclay GR, Turnberg LA. Effect of cold-induced pain on salt and water transport in the human jejunum. Gastroenterology 1988;94:994-8.
154. Stanghellini V, Malagelada J-R, Zinsmeister AR, Go VLW, Kao PC. Stress-induced gastroduodenal motor disturbances in humans: possible humoral mechanisms. Gastroenterology 1983;85:83-91.
155. Stanghellini V, Malagelada J-R, Zinsmeister AR, Go VLW, Kao PC. Effect of opiate and adrenergic blockers on the gut motor response to centrally acting stimuli. Gastroenterology 1984;87:1104-13.
156. Welgan P, Meshkinpour H, Beeler M. Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology 1988;94:1150-6.
157. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002;122:1778-83.
158. Mayer EA, Naliboff BD, Chang L, Coutinho SV. Stress and the gastrointestinal tract. V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001;280:G519-24.
159. Weston AP, Biddle WL, Bhatia PS, Miner PB. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993;38:1590-5.
160. O'Sullivan M, Clayton N, Breslin NP, Harman I, Bountra C, McLaren A, et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000;12:449-57.
161. Park CH, Joo YE, Choi SK, Rew JS, Kim SJ, Lee MC. Activated mast cells infiltrate in close proximity to enteric nerves in diarrhea-predominate irritable bowel syndrome. J Korean Med Sci 2003;18:204-10.
162. MacQueen G, Marshall J, Perdue M, Siegel S, Bienenstock J. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 1989;243:83-5.
163. Gauci M, Husband AF, Saxarra H, King MG. Pavlovian conditioning of nasal tryptase release in human subjects with allergic rhinitis. Physiol Behav 1994;55:823-5.
164. Guilarte M, Santos J, Alonso C, Vicario M, Antolin M, Saperas E, et al. Corticotropin-releasing hormone (CRH) triggers jejunal mast cell and eosinophil activation in IBS patients. Gastroenterology 2004;126 Suppl 2:A38.
165. Cherner JA, Jensen RT, Dubois A, O'Dorisio TM, Gardner JD, Metcalfe DD. Patients with increased gastrointestinal mast cells also display similar symptoms to IBS patients. Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. Gastroenterology 1988;95:657-67.
166. Holmes DR Jr, Savage M, LaBlanche JM, Grip L, Serruys PW, Fitzgerald P, et al. Results of prevention of REStenosis with tranilast and its outcomes (PRESTO) trial. Circulation 2002;106:1243-50.
167. Louis R. Anti-IgE: A significant breakthrough in the treatment of airway allergic diseases. Allergy 2004;59:698-700.
168. Wong RB, a treatment for allergic and autoimmune diseases. Expert Opin Investig Drugs 2004; 13. In press.